AdAlta
Business Services · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
697 Burke Rd Se 201, Camberwell, Victori...Phone Number
+61 394795159Website
www.adalta.com.auRevenue
<$5 MillionStock Symbol
1ADIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About AdAlta
AdAlta is focused on developing innovative solutions for debilitating diseases through its i-body® drug discovery platform, which offers new therapeutic options where traditional antibodies fall short. The company specializes in next-generation protein and cell therapies, particularly targeting fibrosis and immuno-oncology. Their lead asset, AD-214, is a first-in-class product aimed at treating fibrotic diseases and providing hope for patients with solid tumors. Additionally, AdAlta is advancing i-CAR-T cell therapies and i-PET imaging to enhance cancer treatment outcomes.Explore more
AdAlta Org Chart
AT
Senior Director, Operations
DB
Director, Clinical & Regulatory Operations
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AdAlta your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if AdAlta has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on AdAlta recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if AdAlta is spiking on competitors!
AdAlta, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if AdAlta had a recent Job posting/layoffs
Product Launch: Get notified when AdAlta launches new products
Funding: Get notified immidiatlly once AdAlta has new funding data
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at AdAlta
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to AdAlta
Compare insights from companies similar to AdAlta, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
AdAlta is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
AdAlta is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about AdAlta.
AdAlta financials insights
Gather financial insights about AdAlta, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Other Financing Round
$325K
2026
Stock/Share Issuance
$1.8M
AdAlta Tech Stack
A closer look at the technologies used by AdAlta
See more technologies
Most Recent Scoops
Person-Based
Medical Research
Person-Based
Medical Research
Person-Based
Partnership, Corporate Strategy
Person-Based
Events, Business Development
Person-Based
Partnership, Pharmaceuticals, Artificial Intelligence
Top Business Services Companies
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding AdAlta
Sign Up For FreeTo access detailed company insights
AdAlta is focused on developing innovative solutions for debilitating diseases through its i-body® drug discovery platform, which offers new therapeutic options where traditional antibodies fall short. The company specializes in next-generation protein and cell therapies, particularly targeting fibrosis and immuno-oncology. Their lead asset, AD-214... Read More
